Astellas confirms plans to invest $257mn to develop R&D facilities in Japan and US

By Sean Galea-Pace
The Japan-based pharmaceutical company, Astellas Pharma, has announced it plans to invest $257mn to develop new R&D manufacturing facilities in thre...

The Japan-based pharmaceutical company, Astellas Pharma, has announced it plans to invest $257mn to develop new R&D manufacturing facilities in three sites in Japan and the US, BioPharmaDive reports.

It has been revealed that Astellas will create two centres in Japan, Toyama and Tsukuba, with both anticipated to be completed in 2019, in addition to one in Massachusetts, which is expected to reach completion in January 2020.

The new facility in Tsukuba is thought to cost around $44mn and will have the capability to develop clinical trial materials that can be utilised for Phase 1 and Phase 2 studies of cell and gene therapies in Japan, the US and Europe.  

See more:

In Toyama, Astellas are expected to invest almost $90mn to develop an 8,000 square-metre facility to create antibodies for both clinical and commercial uses.

However, the largest development is set to take place in the US with a new location of 24,000 square metres of its Institute for Regenerative Medicine.

The news follows Astellas recent movements in the last few years which has seen the company complete three deals to purchase assets in gene therapy, women’s health and mitochondrial research.

Share

Featured Articles

Microsoft’s Çağlayan Arkan explores the supply chain

Çağlayan Arkan, Microsoft’s VP Global Strategy & Sales Lead for Manufacturing & Supply Chain, gives his take on digital factories and ‘the art of possible’

Elisabeth Brinton on the Microsoft Cloud for Sustainability

Microsoft’s Elisabeth Brinton discusses the Microsoft Cloud for Sustainability programme & how manufacturers are being supported by their new technology

Aiimi’s Head of Solution Engineering Matt Eustace on risks

Aiimi utilises AI to provide businesses insights that eliminate risks ‒ including how to manage sanctioned individuals in your supply chain

5 minutes with Nicolai Peitersen, co-founder of Wikifactory

Procurement & Supply Chain

Three steps to building a resilient enterprise ecosystem

Procurement & Supply Chain

Chocolate manufacturer Venchi on sustainable packaging

Procurement & Supply Chain